Modulating PD1 Pathway in PBMC
Corresponding Organization :
Other organizations : Lepra Society, The University of Texas Health Science Center at Tyler
Variable analysis
- Presence or absence of γ-Mtb CFP-10 + ESAT-6 (10 μg/ml)
- Presence or absence of anti-PD1 antibody (10 μg/ml)
- Cytokine concentrations in cell-free culture supernatants (measured by ELISA)
- Cell culture medium (RPMI 1640 containing 1% penicillin/streptomycin, L-Glutamine and 10% heat-inactivated human serum)
- Cell density (2 × 10^6 cells/well)
- Incubation conditions (37 °C, 5% CO2, humidified atmosphere)
- Incubation duration (96 h)
- Positive control: Cells cultured with γ-Mtb CFP-10 + ESAT-6 (10 μg/ml)
- Negative control: Cells cultured without γ-Mtb CFP-10 + ESAT-6
- PD1 inhibition control: Cells cultured with isotype control antibody (concentration not specified)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!